Summit Therapeutics' drug achieves $1 billion in sales by end of 2025? | Binary | | | 7 months ago | |
FDA approval for Summit's cancer drug by end of 2024? | Binary | | | 7 months ago | |
Next steps for Summit's cancer drug in the US market by end of 2024? | Categorical | | | 7 months ago | |
Summit's partnerships for global distribution by end of 2024? | Categorical | | | 7 months ago | |
Primary endpoint for Summit's drug in comparative US study by mid-2025? | Categorical | | | 7 months ago | |
What will be Summit's revenue from their lung cancer drug by end of 2024? | Categorical | | | 7 months ago | |
How will Summit's share price perform by end of 2024? | Categorical | | | 7 months ago | |
Will Summit's lung cancer drug receive FDA approval by end of 2024? | Binary | | | 7 months ago | |
Will Summit's market cap exceed 10 billion USD by end of 2024? | Binary | | | 7 months ago | |
Will Summit's lung cancer drug outperform Keytruda in a US-based trial by end of 2024? | Binary | | | 7 months ago | |
In which markets will Summit's lung cancer drug receive approval by end of 2024? | Categorical | | | 7 months ago | |
Summit Therapeutics submits FDA approval application for Ivonescimab by 2024? | Binary | | | 7 months ago | |
Ivonescimab receives FDA approval by mid-2025? | Binary | | | 7 months ago | |
Summit Therapeutics' market cap exceeds $10 billion by mid-2024? | Binary | | | 7 months ago | |
Summit Therapeutics' next step for Ivonescimab by end of 2024? | Categorical | | | 7 months ago | |
Summit Therapeutics' stock price at end of 2024? | Categorical | | | 7 months ago | |
Next key regulatory milestone for Ivonescimab by end of 2024? | Categorical | | | 7 months ago | |
Summit Therapeutics stock price above $10 by August 31, 2024? | Binary | | | 7 months ago | |
Ivonescimab FDA approval for NSCLC by end of 2024? | Binary | | | 7 months ago | |
Next milestone for Ivonescimab by end of 2024? | Categorical | | | 7 months ago | |
Company with highest stock increase in 2024 following Ivonescimab news? | Categorical | | | 7 months ago | |
Summit Therapeutics' market cap reaches $10 billion by mid-2025? | Binary | | | 7 months ago | |
Merck files legal challenge against Summit Therapeutics by end of 2024? | Binary | | | 7 months ago | |
Peak market cap of Summit Therapeutics in 2024? | Categorical | | | 7 months ago | |
